Followers | 2431 |
Posts | 91296 |
Boards Moderated | 7 |
Alias Born | 09/12/2003 |
![](https://investorshub.advfn.com/uicon/26252.png?cb=1665110536)
Thursday, June 29, 2023 3:09:45 AM
Company website https://pluripain.com/
BioAdaptives Announces Initial Investigation Results Pluripain® Improves Symptoms of Gadolinium Deposition Disease
BDPT) announced today positive results from a study conducted by Stanford Medical School Professor, Lorrin Koran, M.D., regarding the use of Pluripain® to manage the symptoms of Gadolinium Deposition Disease (GDD). The investigation revealed that 60% of GDD patients in the initial study reported a significant decrease in pain and/or brain fog, while using this supplement formula. In some cases, patients were able to decrease their dependence on opioid pain killers with continued use of Pluripain®.
https://www.marketscreener.com/quote/stock/BIOADAPTIVES-INC-120796204/news/BioAdaptives-Announces-Initial-Investigation-Results-Pluripain-Improves-Symptoms-of-Gadolinium-Depo-39567441/
WHAT IS PLURIPAIN®? is a safe, all-natural pain relief supplement formula to manage your aching joints, sore back and other pains.
![](http://investorshub.advfn.com/uimage/uploads/2023/6/29/dityfScreenshot_(30).png)
What is Pain?
Pain is the number one reason why people use drugs or seek medical care.
Pain is not a disease.
Pain is an unpleasant feeling that occurs as a result of a problem.
Pain is an important “alarm bell” that rings when something goes wrong somewhere in the body.
https://pluripain.com/pluripain-english/
![Bullish](/static/images/ih2-bull.png)
Recent BDPT News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 10:00:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/17/2024 08:10:09 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:17:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:06:28 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 10/11/2023 07:59:24 PM
- Form 1-Z - • Edgar (US Regulatory) • 08/24/2023 06:40:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:16:40 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM